JCF Intersections

JCF-Intersections welcomes diverse perspectives on the intersections of cardiovascular patient care. Submit your work today! 🗳️

Information for Authors: bit.ly/40hRwt7

#Cardiology #HeartFailure

What drives patients with ATTR-CM and families to pursue genetic testing? 🧬

✨ Provider trust & duty to family were top motivators
🧠 Patients wanted more info on risks, esp. insurance
📉 Testing was easy, but emotionally taxing
🤝Clear need for better consent, counseling & support.

🔗 bit.ly/4lWnlAt

Have groundbreaking research on the intersections of patient care?

Submit to JCF-Intersections and contribute to the global conversation 🌎

Information for Authors: https://bit.ly/40hRwt7

#Cardiology #HeartFailure

🩺 New in JCF–I:
CKM syndrome is a leading cause of cardiovascular disease, yet our care systems remain fragmented.

🔹 An integrated practice model
🔹 Stage-based risk pathways
🔹 Scalable, tech-enabled care
🔹 Value-based reimbursement strategies

🔗 bit.ly/3IK7lTB

Role of Rhythm Control With Antiarrhythmic Agents in Heart Failure With Preserved Ejection Fraction: Insights From the AFFIRM Trial Atrial fibrillation (AF) is common in heart failure with preserved ejection fraction (HFpEF) and optimal therapeutic strategies remain unknown. This post-hoc analysis of the AFFIRM trial evaluates the...

🚨 The inaugural publication in JCF–Intersections is here!
AFFIRM sub-analysis:

✅ AADs effective for sinus rhythm in HFpEF
⚠️ Class Ic & sotalol ↑ mortality
✔️ Amiodarone may be safer

A strong call for HFpEF recognition & precision in rhythm control.
🔗 www.onlinejcfi.org/article/S305...

Real-world wisdom, distilled.

“Teachable Moments” in JCF-Intersections features practical insights from the frontlines of heart failure care — submit today: bit.ly/44I4YYE

#MedicalEducation #HeartFailure #Cardiology

🩺 Ready to publish with JCF-Intersections?
Whether you're innovating in training, sharing clinical pearls, or sparking a debate—there's a section for your voice. Submit today: https://bit.ly/44I4YYE

💡 Training | ⚕️ Teachable Moments | ⚖️ Debates

#MedEd #HeartFailure #Cardiology

Collaboration is key in advancing heart failure care. Share your research with JCF-Intersections and be part of a global community.

Information for Authors: Journal of Cardiac Failure - Intersections: 🔗http://bit.ly/3IifiPi

#Cardiology #HeartFailure

We’re cultivating exciting new opportunities for scientific dialogue at JCF-Intersections! What would you like to see in our inaugural issues?

✅ Debates on Hot Topics
✅ Clinical Pearls
✅ Patient Perspectives

Something else? Let us know in the comments🗳️

Have a breakthrough at the intersection of heart failure and cardiovascular care? Share it with JCF-Intersections and contribute to the global medical community.

Information for Authors: Journal of Cardiac Failure - Intersections: 🔗 http://bit.ly/3IifiPi

#Cardiology #HeartFailure

Join the conversation on the intersections between heart failure and cardiovascular care with JCF-Intersections.

Follow us for the latest updates and discussions.

#Cardiology #HeartFailure

Join the JCF-Intersections community and contribute to the dialogue on intersections of cardiovascular care.

Information for Authors: Journal of Cardiac Failure - Intersections: 🔗http://bit.ly/3IifiPi

#Cardiology #HeartFailure

At JCF-Intersections, we believe in cultivating collaborations at the intersections of heart failure, cardiovascular medicine, and beyond.

Let's work together to bridge across silos to advance patient care!

#Cardiology #HeartFailure #HeartFunction

Share your "How I Do It"!

JCFI’s “Teachable Moments” highlights expert perspectives on advanced HF practice — real lessons from real clinicians!

📌 1000–1200 words, up to 5 references

Submit Today: https://bit.ly/3FT5o6e

#MedicalEducation #HeartFailure #Cardiology

Your research matters.

Share it with JCF-Intersections and make an impact at the intersections of care.

Submit your research today at: https://www.editorialmanager.com/jcf-i/default2.aspx

#Cardiology #HeartFailure

How would you reimagine HF training? JCF-I highlights trailblazing approaches in advanced HF ed- from AI fellowships to palliative integration.

We want your story.

🧠 Word count: 1000–1500
📊 Up to 2 figures

Submit your paper today! bit.ly/3FT5o6e
#CardioEd #HeartFailure #Cardiology

Two Takes, One Conversation.

It’s Up For Debate invites authors to explore advanced HF controversies—opposing perspectives welcome. Submit paired manuscripts (750–1000 words) on timely clinical or research issues.

Submit Today: www.editorialmanager.com/jcf-i/defaul...
#HeartFailure #Cardiology

Call for Submissions: JCF-Intersections’ Intersections in Training seeks stories of innovation in heart failure education—AI integration, novel fellowships, cross-discipline collabs. Word limit: 1,500.

Submit here: https://www.editorialmanager.com/jcf-i/default2.aspx

#CardioEd #HeartFailure

Proud to announce the launch of JCF-Intersections, a journal dedicated to innovative discoveries at the intersections of heart function and cardiovascular care.

Check out our Information for Authors and join us! https://www.onlinejcfi.org/content/authorinfo

#Cardiology #HeartFailure #HeartFunction

Our mission at JCF-Intersections is to break down silos in patient care and bring together different medical disciplines.

Let's collaborate for better patient outcomes.
https://www.onlinejcfi.org/content/authorinfo

#Cardiology #HeartFailure #JCFIntersections

Looking to publish your research? JCF-Intersections welcomes submissions spanning original science, state-of-the-art reviews, perspectives, and patient-partner narratives.

Submit today! www.onlinejcfi.org/content/auth...

#Cardiology #HeartFailure #HeartFunction

Explore cutting-edge original research, innovative perspectives, and more in heart failure and cardiology with JCF-Intersections.

Find out more: www.onlinejcfi.org/content/auth...

#Cardiology #HeartFailure #JCFIntersections

⏳ Time is running out to apply for the JCF 2025–26 Reviewer Mentorship Program!

Open to early career clinicians in all specialties, including international applicants.

Don't miss out! Applications due by tomorrow May 16th - no exceptions.

🔗 hfsa.org/jcf-reviewer...

Checking in from Boston 👋

Dr. Jason Katz is at the 45th annual #ISHLT Meeting, where experts from around the world are coming together to advance the field of heart & lung transplantation.

We’re excited to hear his perspective and to share the key takeaways with you all soon!

#JCFI #ISHLT2025

Welcome Dr. Hawkins Gay, JCF-I Associate Editor. Dr. Gay is a Cardiac Electrophysiologist at Northwestern Medicine. With a Master’s in Public Health & a Master’s in AI, his research focuses on integrating digital health tools & AI in clinical care to improve patient outcomes.

Welcome JCF-I Associate Editor Dr. Elliott Miller. Dr. Miller is an Assist. Prof. at Yale School of Medicine & Medical Dir. of the Cardiac ICU at Yale New Haven Hospital. His research focuses on the intersection of critical care & cardiovascular medicine.

Welcome JCF-I Associate Editor Dr. Shahzeb Khan. Dr. Khan is a board-certified cardiologist & an internationally recognized expert in cardiometabolic diseases, cardio-oncology, and HF. Dr. Khan has authored over 400 peer-reviewed publications.

#Cardiology #HeartFailure

Welcome Dr. Julie Doberne Associate Editor for JCF-I. Dr. Doberne is a cardiac surgeon-informatician & an Assist. Prof. at OHSU. Her research focuses on EHR impact, surgeon workflow, & machine learning-driven image analysis, bridging the gap between surgery & technology.

Welcome JCF-I Associate Editor Dr. Sarah Chuzi. Dr. Chuzi is an Adv HF & Transplant Cardiologist at Northwestern Medicine & Director of Adv HF at the Jesse Brown VA Medical Center. Her work focuses on palliative care in heart failure, aiming to improve goal-concordant & end-of-life care.

Welcome Dr. Anthony Carnicelli Associate Editor for JCF-I. Dr. Carnicelli is an Asst. Prof. of Medicine & Adv HF/Transplant Cardiologist & Director of the Cardiac ICU at Medical University of SC. His research focuses on cardiogenic shock, HF therapies, transplantation, & device development.